Differential effect of ouabain on glucose-induced biphasic insulin release in vitro.
D000818:Animals; D004357:Drug Synergism; D005947:Glucose / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D010042:Ouabain / Q000494:pharmacology*; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D010477:Perfusion; D011863:Radioimmunoassay; D051381:Rats; D013806:Theophylline / Q000037:antagonists & inhibitors / Q000494:pharmacology
D007328:Insulin; D010042:Ouabain; D013806:Theophylline; D005947:Glucose